Negative impact of laws regarding biosecurity and bioterrorism on real diseases

Clinical Microbiology and Infection

Volumn 20, Issue 6, 2014, Pages 507-515

  Wurtz, N ^a   Grobusch, M P ^b   Raoult, D ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biosafety; Biosafety laboratory; Biosecurity; Bioterrorism; Infectious disease; Laws; Limitations; Regulations; Select agent and toxins

Indexed keywords

ANTHRAX VACCINE; BIOLOGICAL PRODUCT; SMALLPOX VACCINE; TOXIN; BIOLOGICAL WARFARE AGENT;

ANTHRAX; ARMY; AUTHORITY; BIOLOGICAL WARFARE; BIOSAFETY; HAZARD; HUMAN; LABORATORY; LAW; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SCIENTIST; SMALLPOX; SOCIAL SECURITY; BIOLOGICAL WARFARE AGENT; HAZARDOUS WASTE; LEGISLATION AND JURISPRUDENCE; MEDICAL RESEARCH; MICROBIOLOGICAL EXAMINATION; PROCEDURES; STANDARDS; TOXICOLOGY; UNITED STATES;

BIOLOGICAL WARFARE AGENTS; BIOMEDICAL RESEARCH; CONTAINMENT OF BIOHAZARDS; HUMANS; MICROBIOLOGICAL TECHNIQUES; TOXICOLOGY; UNITED STATES;

EID: 84904394581     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12709     Document Type: Review

References (37)

1. Inglesby TV, Dennis DT, Henderson DA et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000; 283: 2281-2290.
2. Jacobs MK. The history of biologic warfare and bioterrorism. Dermatol Clin 2004; 22: 231-246.
3. Meselson M, Guillemin J, Hugh-Jones M et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994; 266: 1202-1208.
4. Inglesby TV, O'Toole T, Henderson DA et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287: 2236-2252.
5. Klietmann WF, Ruoff KL. Bioterrorism: implications for the clinical microbiologist. Clin Microbiol Rev 2001; 14: 364-381.
6. Bhattacharjee Y. Anthrax investigation. Army missed warning signs about alleged anthrax mailer. Science 2011; 332: 27.
7. McConnell J, Raoult D. Emerging respiratory viruses: is it 'much ado about nothing'? (Shakespeare). Clin Microbiol Infect 2014; 20: 187-188.
8. Borgdorff MW, van Soolingen D. The re-emergence of tuberculosis: what have we learnt from molecular epidemiology? Clin Microbiol Infect 2013; 19: 889-901.
9. Bossi P, Garin D, Guihot A et al. Bioterrorism: management of major biological agents. Cell Mol Life Sci 2006; 63: 2196-2212.
10. Thibault FN, Forcet S, Lachenaud L, Vidal D. Réponse à la menace biologique: le réseau des laboratoires Biotox-Piratox. Revue Francophone des Laboratoires 2009; 2009: 71-75.
11. Fauci AS. Emerging and reemerging infectious diseases: the perpetual challenge. Acad Med 2005; 80: 1079-1085.
12. Feldmann H, Czub M, Jones S et al. Emerging and re-emerging infectious diseases. Med Microbiol Immunol 2002; 191: 63-74.
13. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature 2004; 430: 242-249.
14. Tucker JB. Historical trends related to bioterrorism: an empirical analysis. Emerg Infect Dis 1999; 5: 498-504.
15. Brachman PS. Bioterrorism: an update with a focus on anthrax. Am J Epidemiol 2002; 155: 981-987.
16. Chapman AS, Bakken JS, Folk SM et al. Diagnosis and management of tickborne rickettsial diseases: rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55: 1-27.
17. Oyston PC, Sjostedt A, Titball RW. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2004; 2: 967-978.
18. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6: 91-99.
19. Svraka S, Rolain JM, Bechah Y, Gatabazi J, Raoult D. Rickettsia prowazekii and real-time polymerase chain reaction. Emerg Infect Dis 2006; 12: 428-432.
20. Carus WS. Bioterrorism and biocrimes: the illicit use of biological agents since 1900. Fredonia Books: Amsterdam, 2002.
21. Jaax J. Administrative issues related to infectious disease research in the age of bioterrorism. ILAR J 2005; 46: 8-14.
22. Hayden EC. Biodefence since 9/11: the price of protection. Nature 2011; 477: 150-152.
23. Dias MB, Reyes-Gonzalez L, Veloso FM, Casman EA. Effects of the USA PATRIOT Act and the 2002 Bioterrorism Preparedness Act on select agent research in the United States. Proc Natl Acad Sci USA 2010; 107: 9556-9561.
24. Shurtleff AC, Garza N, Lackemeyer M et al. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment. Viruses 2012; 4: 3932-3951.
25. Tierno A, Plateau E. Biosecurity, biosafety and reference laboratories: the impact of national and European regulations concerning biological containment levels 3 and 4. EuroReference 2012; 7(Special 'security and safety').
26. Arrêté du 11 juin 2013 modifiant l'arrêté du 23 janvier 2013 relatif aux règles de bonnes pratiques tendant à garantir la sécurité et la sûreté biologiques mentionnés à l'article R. 5139 18 du code de la santé publique. 2014. Available at: http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000027607859&dateTexte=&categorieLien=id (Accessed 30 April 2014).
27. Barquet N, Domingo P. Smallpox: the triumph over the most terrible of the ministers of death. Ann Intern Med 1997; 127(8 Pt 1): 635-642.
28. Shchelkunov SN. How long ago did smallpox virus emerge? Arch Virol 2009; 154: 1865-1871.
29. Radetsky M. Smallpox: a history of its rise and fall. Pediatr Infect Dis J 1999; 18: 85-93.
30. World Health Organization Advisory Committee on Variola Virus Research WHO report of the ninth meeting, Geneva, Switzerland, November 29-30, 2007. Geneva: WHO, 2008; 2
31. Mahy BW, Almond JW, Berns KI et al. The remaining stocks of smallpox virus should be destroyed. Science 1993; 262: 1223-1224.
32. World Health Assembly Resolution, WHA 60.1. Smallpox eradication: destruction of variola virus stocks, 2010. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHASSA_WHA60-Rec1/E/reso-60-en.pdf (Accessed 30 April 2014).
33. Sixty-Fourth World Health Assembly, A64/17, Provisional agenda item 13.8. Smallpox eradication: destruction of variola virus stocks, Report by the Secretariat, 2011. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_17-en.pdf (Accessed 30 April 2014).
34. Sixty-fourth World Health Assembly, daily notes on proceedings. Available at: http://www.who.int/mediacentre/events/2011/wha64/journal/en/index8.html (Accessed 30 April 2014).
35. Raoult D, Raoult S. Le bioterrorisme: la peur à bon marché = Bioterrorism: cost-price fear. Revue des sciences sociales 2006; 35: 54-59.
36. Biagini P, Theves C, Balaresque P et al. Variola virus in a 300-year-old Siberian mummy. N Engl J Med 2012; 367: 2057-2059.
37. Décret n 2010-736 du 30 juin 2010 relatif aux micro-organismes et toxines. Available at: http://legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000022415024&categorieLien=id (Accessed 30 April 2014).